APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticancer Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anticancer Drugs Industry Growth and Trends Forecast to 2032

23 December 2025120 pages

Choose your research edition.

Industry ResearchAnticancer Drugs Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticancer Drugs Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Anticancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticancer Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticancer Drugs Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Anticancer Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anticancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anticancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anticancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Anticancer Drugs market include Takeda, Johnson & Johnson, Novartis, Merck KGaA, Roche, Eli Lilly, Gilead Sciences, Pfizer and Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anticancer Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anticancer Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anticancer Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anticancer Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Anticancer Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anticancer Drugs Market by Company

Takeda

Johnson & Johnson

Novartis

Merck KGaA

Roche

Eli Lilly

Gilead Sciences

Pfizer

Hengrui Medicine

GSK

Bristol-Myers Squibb

Amgen

AbbVie

AstraZeneca

Seagen

Regeneron

Ono Pharmaceutical

Merck & Co

Innovent

Exelixis

Anticancer Drugs Segment by Type

Cancer Immunotherapy

Chemotherapy

Targeted Therapy

Other

Anticancer Drugs Segment by Application

Blood-related Cancer

Breast Cancer

Prostate Cancer

Lung Cancer

Other

Anticancer Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Anticancer Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Anticancer Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Anticancer Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Anticancer Drugs Market Share by Region (2021-2026) Table 4. Global Anticancer Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Anticancer Drugs Market Share by Region (2027-2032) Table 6. Global Anticancer Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anticancer Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Anticancer Drugs Market Size Share by Type (2021-2026) Table 9. Global Anticancer Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Anticancer Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Anticancer Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Anticancer Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Anticancer Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Anticancer Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Anticancer Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Anticancer Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Anticancer Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Anticancer Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Anticancer Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Anticancer Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Anticancer Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Anticancer Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Anticancer Drugs Market Size Share by Application (2021-2026) Table 24. Global Anticancer Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Anticancer Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Anticancer Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Anticancer Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Anticancer Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Anticancer Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Anticancer Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Anticancer Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Anticancer Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Anticancer Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Anticancer Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Anticancer Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Anticancer Drugs Industry Trends Table 37. Anticancer Drugs Industry Drivers Table 38. Anticancer Drugs Industry Opportunities and Challenges Table 39. Anticancer Drugs Industry Restraints Table 40. Global Anticancer Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Anticancer Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Anticancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Anticancer Drugs Key Company Headquarters & Area Served Table 44. Global Anticancer Drugs Company, Product Type & Application Table 45. Global Anticancer Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Anticancer Drugs Product Portfolio Table 52. Takeda Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Anticancer Drugs Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Anticancer Drugs Product Portfolio Table 62. Novartis Recent Development Table 63. Merck KGaA Company Information Table 64. Merck KGaA Business Overview Table 65. Merck KGaA Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck KGaA Anticancer Drugs Product Portfolio Table 67. Merck KGaA Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Roche Anticancer Drugs Product Portfolio Table 72. Roche Recent Development Table 73. Eli Lilly Company Information Table 74. Eli Lilly Business Overview Table 75. Eli Lilly Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Eli Lilly Anticancer Drugs Product Portfolio Table 77. Eli Lilly Recent Development Table 78. Gilead Sciences Company Information Table 79. Gilead Sciences Business Overview Table 80. Gilead Sciences Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Gilead Sciences Anticancer Drugs Product Portfolio Table 82. Gilead Sciences Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Pfizer Anticancer Drugs Product Portfolio Table 87. Pfizer Recent Development Table 88. Hengrui Medicine Company Information Table 89. Hengrui Medicine Business Overview Table 90. Hengrui Medicine Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Hengrui Medicine Anticancer Drugs Product Portfolio Table 92. Hengrui Medicine Recent Development Table 93. GSK Company Information Table 94. GSK Business Overview Table 95. GSK Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GSK Anticancer Drugs Product Portfolio Table 97. GSK Recent Development Table 98. Bristol-Myers Squibb Company Information Table 99. Bristol-Myers Squibb Business Overview Table 100. Bristol-Myers Squibb Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bristol-Myers Squibb Anticancer Drugs Product Portfolio Table 102. Bristol-Myers Squibb Recent Development Table 103. Amgen Company Information Table 104. Amgen Business Overview Table 105. Amgen Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Amgen Anticancer Drugs Product Portfolio Table 107. Amgen Recent Development Table 108. AbbVie Company Information Table 109. AbbVie Business Overview Table 110. AbbVie Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. AbbVie Anticancer Drugs Product Portfolio Table 112. AbbVie Recent Development Table 113. AstraZeneca Company Information Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AstraZeneca Anticancer Drugs Product Portfolio Table 117. AstraZeneca Recent Development Table 118. Seagen Company Information Table 119. Seagen Business Overview Table 120. Seagen Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Seagen Anticancer Drugs Product Portfolio Table 122. Seagen Recent Development Table 123. Regeneron Company Information Table 124. Regeneron Business Overview Table 125. Regeneron Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Regeneron Anticancer Drugs Product Portfolio Table 127. Regeneron Recent Development Table 128. Ono Pharmaceutical Company Information Table 129. Ono Pharmaceutical Business Overview Table 130. Ono Pharmaceutical Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Ono Pharmaceutical Anticancer Drugs Product Portfolio Table 132. Ono Pharmaceutical Recent Development Table 133. Merck & Co Company Information Table 134. Merck & Co Business Overview Table 135. Merck & Co Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Merck & Co Anticancer Drugs Product Portfolio Table 137. Merck & Co Recent Development Table 138. Innovent Company Information Table 139. Innovent Business Overview Table 140. Innovent Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Innovent Anticancer Drugs Product Portfolio Table 142. Innovent Recent Development Table 143. Exelixis Company Information Table 144. Exelixis Business Overview Table 145. Exelixis Anticancer Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Exelixis Anticancer Drugs Product Portfolio Table 147. Exelixis Recent Development Table 148. North America Anticancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Anticancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Anticancer Drugs Market Share by Country (2021-2026) Table 151. North America Anticancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Anticancer Drugs Market Share Forecast by Country (2027-2032) Table 153. Europe Anticancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Anticancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Anticancer Drugs Market Share by Country (2021-2026) Table 156. Europe Anticancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Anticancer Drugs Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Anticancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Anticancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Anticancer Drugs Market Share by Country (2021-2026) Table 161. Asia-Pacific Anticancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Anticancer Drugs Market Share Forecast by Country (2027-2032) Table 163. Latin America Anticancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Anticancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Anticancer Drugs Market Share by Country (2021-2026) Table 166. Latin America Anticancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Anticancer Drugs Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Anticancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Anticancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Anticancer Drugs Market Share by Country (2021-2026) Table 171. Middle East & Africa Anticancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Anticancer Drugs Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Anticancer Drugs Product Image Figure 3. Global Anticancer Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Anticancer Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Anticancer Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Anticancer Drugs Market Share by Region (2021-2032) Figure 7. North America Anticancer Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Anticancer Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Anticancer Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Anticancer Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Anticancer Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cancer Immunotherapy Image Figure 13. Global Cancer Immunotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Chemotherapy Image Figure 15. Global Chemotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Targeted Therapy Image Figure 17. Global Targeted Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Anticancer Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Anticancer Drugs Market Share by Type 2025 VS 2032 Figure 22. North America Anticancer Drugs Market Size Share by Type (2021-2032) Figure 23. Europe Anticancer Drugs Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Anticancer Drugs Market Size Share by Type (2021-2032) Figure 25. Latin America Anticancer Drugs Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Anticancer Drugs Market Size Share by Type (2021-2032) Figure 27. Blood-related Cancer Image Figure 28. Global Blood-related Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Breast Cancer Image Figure 30. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Prostate Cancer Image Figure 32. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Lung Cancer Image Figure 34. Global Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Other Image Figure 36. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Anticancer Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Anticancer Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Anticancer Drugs Market Size Share by Application (2021-2032) Figure 40. Europe Anticancer Drugs Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Anticancer Drugs Market Size Share by Application (2021-2032) Figure 42. Latin America Anticancer Drugs Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Anticancer Drugs Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Anticancer Drugs Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Anticancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Anticancer Drugs Market Share by Country (2021-2032) Figure 49. Europe Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Anticancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anticancer Drugs Market Share by Country (2021-2032) Figure 52. Asia-Pacific Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Anticancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Anticancer Drugs Market Share by Country (2021-2032) Figure 55. Latin America Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anticancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anticancer Drugs Market Share by Country (2021-2032) Figure 58. Middle East & Africa Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Anticancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Anticancer Drugs Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Cancer Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Other
Applications
  • Blood-related Cancer
  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Other
Companies covered
  • Takeda
  • Johnson & Johnson
  • Novartis
  • Merck KGaA
  • Roche
  • Eli Lilly
  • Gilead Sciences
  • Pfizer
  • Hengrui Medicine
  • GSK
  • Bristol-Myers Squibb
  • Amgen
  • AbbVie
  • AstraZeneca
  • Seagen
  • Regeneron
  • Ono Pharmaceutical
  • Merck & Co
  • Innovent
  • Exelixis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Anticancer Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Anticancer Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Anticancer Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Anticancer Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Anticancer Drugs Market Size (2021-2032)
  8. 1.5.1 North America Anticancer Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Anticancer Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Anticancer Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Anticancer Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Anticancer Drugs Market Size Growth Rate (2021-2032)
2 Anticancer Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cancer Immunotherapy
  3. 2.1.2 Chemotherapy
  4. 2.1.3 Targeted Therapy
  5. 2.1.4 Other
  6. 2.2 Global Anticancer Drugs Market Size by Type
  7. 2.2.1 Global Anticancer Drugs Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Anticancer Drugs Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Anticancer Drugs Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Anticancer Drugs Market Size by Regions
  11. 2.3.1 North America Anticancer Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Anticancer Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Anticancer Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Anticancer Drugs Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Anticancer Drugs Market Size Breakdown by Type (2021-2026)
3 Anticancer Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Blood-related Cancer
  3. 3.1.2 Breast Cancer
  4. 3.1.3 Prostate Cancer
  5. 3.1.4 Lung Cancer
  6. 3.1.5 Other
  7. 3.2 Global Anticancer Drugs Market Size by Application
  8. 3.2.1 Global Anticancer Drugs Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Anticancer Drugs Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Anticancer Drugs Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Anticancer Drugs Market Size by Regions
  12. 3.3.1 North America Anticancer Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Anticancer Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Anticancer Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Anticancer Drugs Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Anticancer Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Anticancer Drugs Industry Trends
  2. 4.2 Anticancer Drugs Industry Drivers
  3. 4.3 Anticancer Drugs Industry Opportunities and Challenges
  4. 4.4 Anticancer Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Anticancer Drugs Revenue (2021-2026)
  2. 5.2 Global Anticancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Anticancer Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Anticancer Drugs Company, Product Type & Application
  5. 5.5 Global Anticancer Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Anticancer Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Anticancer Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Anticancer Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Anticancer Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Anticancer Drugs Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Anticancer Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck KGaA
  20. 6.4.1 Merck KGaA Company Information
  21. 6.4.2 Merck KGaA Business Overview
  22. 6.4.3 Merck KGaA Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck KGaA Anticancer Drugs Product Portfolio
  24. 6.4.5 Merck KGaA Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Roche Anticancer Drugs Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Anticancer Drugs Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Gilead Sciences
  38. 6.7.1 Gilead Sciences Company Information
  39. 6.7.2 Gilead Sciences Business Overview
  40. 6.7.3 Gilead Sciences Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Sciences Anticancer Drugs Product Portfolio
  42. 6.7.5 Gilead Sciences Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Anticancer Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Hengrui Medicine
  50. 6.9.1 Hengrui Medicine Company Information
  51. 6.9.2 Hengrui Medicine Business Overview
  52. 6.9.3 Hengrui Medicine Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Hengrui Medicine Anticancer Drugs Product Portfolio
  54. 6.9.5 Hengrui Medicine Recent Developments
  55. 6.10 GSK
  56. 6.10.1 GSK Company Information
  57. 6.10.2 GSK Business Overview
  58. 6.10.3 GSK Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GSK Anticancer Drugs Product Portfolio
  60. 6.10.5 GSK Recent Developments
  61. 6.11 Bristol-Myers Squibb
  62. 6.11.1 Bristol-Myers Squibb Company Information
  63. 6.11.2 Bristol-Myers Squibb Business Overview
  64. 6.11.3 Bristol-Myers Squibb Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb Anticancer Drugs Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Recent Developments
  67. 6.12 Amgen
  68. 6.12.1 Amgen Company Information
  69. 6.12.2 Amgen Business Overview
  70. 6.12.3 Amgen Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Amgen Anticancer Drugs Product Portfolio
  72. 6.12.5 Amgen Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 AbbVie Anticancer Drugs Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AstraZeneca Anticancer Drugs Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Seagen
  86. 6.15.1 Seagen Company Information
  87. 6.15.2 Seagen Business Overview
  88. 6.15.3 Seagen Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Seagen Anticancer Drugs Product Portfolio
  90. 6.15.5 Seagen Recent Developments
  91. 6.16 Regeneron
  92. 6.16.1 Regeneron Company Information
  93. 6.16.2 Regeneron Business Overview
  94. 6.16.3 Regeneron Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Regeneron Anticancer Drugs Product Portfolio
  96. 6.16.5 Regeneron Recent Developments
  97. 6.17 Ono Pharmaceutical
  98. 6.17.1 Ono Pharmaceutical Company Information
  99. 6.17.2 Ono Pharmaceutical Business Overview
  100. 6.17.3 Ono Pharmaceutical Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Ono Pharmaceutical Anticancer Drugs Product Portfolio
  102. 6.17.5 Ono Pharmaceutical Recent Developments
  103. 6.18 Merck & Co
  104. 6.18.1 Merck & Co Company Information
  105. 6.18.2 Merck & Co Business Overview
  106. 6.18.3 Merck & Co Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Merck & Co Anticancer Drugs Product Portfolio
  108. 6.18.5 Merck & Co Recent Developments
  109. 6.19 Innovent
  110. 6.19.1 Innovent Company Information
  111. 6.19.2 Innovent Business Overview
  112. 6.19.3 Innovent Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Innovent Anticancer Drugs Product Portfolio
  114. 6.19.5 Innovent Recent Developments
  115. 6.20 Exelixis
  116. 6.20.1 Exelixis Company Information
  117. 6.20.2 Exelixis Business Overview
  118. 6.20.3 Exelixis Anticancer Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Exelixis Anticancer Drugs Product Portfolio
  120. 6.20.5 Exelixis Recent Developments
7 North America
  1. 7.1 North America Anticancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Anticancer Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Anticancer Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Anticancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Anticancer Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Anticancer Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Anticancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Anticancer Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Anticancer Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Anticancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Anticancer Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Anticancer Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Anticancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Anticancer Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Anticancer Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst